Imperial College London

Ishihara laboratory

Access / Contact

Publication

2017

Journal

"Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events"
Ishihara J, Fukunaga K, Ishihara A, Larsson HM, Potin L, Hosseinchi P, Galliverti G, Swartz MA, Hubbell JA
Science Translational Medicine 9, 1-16 (2017).

By Year

Tweets byBioengIshihara